Gerber Announces Clean Label Project Certifications of Now More Than 80 Products, the Most of Any Baby Food Brand
Gerber also earns the most First 1,000 Day Promise certifications – the most comprehensive of all Clean Label Project certifications. ARLINGTON, Va., June 20, 2024 /PRNewswire/ -- Gerber, the leader
Nestlé Carnation Evaporated Milk Brings the Heat for National Mac and Cheese Day With First-Ever Flavor Innovation
COFFEE MATE DARES FANS TO SPREAD ICED COFFEE LOVE WITH A BOLD CHALLENGE
Iced coffee fanatics can win $2,500 by shouting "COFFEE MATE HAS NEW COFFEE MATE ICED COFFEE" and posting video proof on TikTok*ARLINGTON, Va., June 18, 2024 /PRNewswire/ -- Calling all courageous co
NESCAFÉ TO CAFFEINATE NATIONAL ICE CREAM DAY WITH LIMITED-EDITION AFFOGATO KITS
Popular TikTok craze inspires kit, bringing the classic Italian dessert to fans' kitchens in an instant with no machine necessary ARLINGTON, Va., June 17, 2024 /PRNewswire/ -- In celebration of Natio
Malaysia Closing Bell on 14 Jun| CDB Was the Top Gainer of FBM KLCI
CDB was the top gainer, rising 1.09 percent to close at RM 3.720. The top loser was PMETAL, losing 3.05 percent to end at RM 5.800.
BNP Paribas Exane Lowers Price Target on Nestle
BNP Paribas Exane lowered its price target on Nestle SA (NESN.SW) to 89 Swiss Francs ($99.43) per share from 92 Swiss Francs per share while maintaining an underperform recommendation on the stock.
Malaysia Closing Bell on 12 Jun| KLK Was the Top Gainer of FBM KLCI
KLKwas the top gainer, rising 1.85 percent to close at RM 20.960. The top loser was PMETAL, losing 1.35 percent to end at RM 5.830.
Deutsche Bank Reduces Nestlé PT, Keeps Rating at Buy
Deutsche Bank on Tuesday lowered the price target of food and beverage giant Nestlé (NESN.SW) to 106 francs from 110 francs and maintained the buy rating.
Malaysia Closing Bell on 11 Jun| DIALOG Was the Top Gainer of FBM KLCI
DIALOG was the top gainer, rising 4.80 percent to close at RM 2.620. The top loser was SIME, losing 3.64 percent to end at RM 2.650.
Nestle Expected With Improved Sales Growth in 2Q -- Market Talk
0941 GMT - Nestle's sales growth is expected to improve on positive calendar effects, easing supply-chain constraints, more new product launches and heavy marketing spending, UBS analysts say in a not
Nestlé's Malaysian Arm to Develop Stable Chili Supply Model With Unity Group
Nestlé's (NESN.SW) Malaysian operating arm agreed to assist green technology company Unity Group in developing a proof of concept model for the latter's agricultural technologies arm Veggity, accordi
Chardan Adjusts PT on Seres Therapeutics to $1.25 From $6 on Heels of Announced MoU With Nestle for Sale of VOWST Assets; Maintains Buy Rating
Chardan Adjusts PT on Seres Therapeutics to $1.25 From $6 on Heels of Announced MoU With Nestle for Sale of VOWST Assets; Maintains Buy Rating.
Nestlé Unit to Buy Vowst Assets From Seres Therapeutics
Seres Therapeutics entered a nonbinding memorandum of understanding to divest its clostridioides difficile infection treatment Vowst to Swiss conglomerate Nestlé's (NESN.SW) nutritional science unit.
Seres Therapeutics Shares Are Lower Higher After the Company Entered a Memorandum of Understanding With Nestlé Health Science for the Sale of Its VOWST Assets. The Stock Initially Traded Higher, but It Has Since Reversed.
Seres Therapeutics Shares Are Lower Higher After the Company Entered a Memorandum of Understanding With Nestlé Health Science for the Sale of Its VOWST Assets. The Stock Initially Traded Higher, but
Nestlé Health Science Agrees to Acquire Global Rights to VOWST, Product It Launched in June 2023
Transaction ensures Nestlé Health Science will continue to commercialize the product BRIDGEWATER, N.J., June 6, 2024 /PRNewswire/ -- Seres Therapeutics, Inc. (Nasdaq: MCRB), announced today that it
Express News | Seres Therapeutics Shares Are Trading Higher After the Company Entered a Memorandum of Understanding With Nestlé Health Science for the Sale of Its VOWST Assets
Press Release: Seres Therapeutics Enters Into Memorandum of Understanding For Vowst(TM) Asset Sale to Nestlé Health Science
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst(TM) Asset Sale to Nestlé Health Science Seres anticipates capital infusions, including an upfront payment, enabling the Company t
Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development
Deerfield Management is pleased to welcome Dr. Frank Nestle, M.D., FMedSci, as Partner on the Therapeutics team and Chief Executive Officer of the...
Malaysia Closing Bell on 05 Jun| TENAGA Was the Top Gainer of FBM KLCI
TENAGA was the top gainer, rising 2.16 percent to close at RM 13.260. The top loser was NESTLE, losing 2.90 percent to end at RM 124.000.
Valbiotis Terminates Licensing, Supply Deal With Nestlé Unit
Valbiotis (ALVAL.PA) and Nestlé's (NESN.SW) Health Science division have terminated their licensing and supply agreement over the plant-based dietary supplement to treat prediabetes and early-stage t
No Data